FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W113160711> ?p ?o ?g. }

• W113160711 endingPage "2202" @default.
• W113160711 startingPage "2197" @default.
• W113160711 abstract "A liver support therapy, named molecular adsorbents recirculating system (MARS), has been used for more than 700 liver failure patients in China. We made here a summary to evaluate the effects of MARS treatment in different applications with emphasis on hepatitis B virus (HBV) based liver failure.This report analyzed data of 252 patients (mean age (44.9+/- 12.7) years) in three groups: acute severe hepatitis (ASH), subacute severe hepatitis (SSH) and chronic severe hepatitis (CSH). The largest group was CSH (156 patients, 61.9%), and 188 patients (74.6%, 188/252) were infected with HBV.MARS treatments were associated with significant reduction of albumin bound toxins and water-soluble toxins. Most of the patients showed a positive response with a significant improvement of multiple organ function substantiated by a significant increase in prothrombin time activity (PTA) and median arterial pressure (MAP). There was a decrease in hepatic encephalopathy (HE) grade and Child-Turcotte-Pugh (CTP) scale. Thirty-nine of 188 HBV patients (20.7%) dropped out of the commendatory consecutive therapy ending with lower survival of 43.6% while the rest of the 149 patients had a survival rate of 62.4%. Survival within the ASH and SSH groups were 81.2% and 75.0%, respectively. In the CSH group, end stage patients were predominant (65/151, 43%), whereas the early and middle stage patients had a better prognosis: early stage survival, including orthotopic liver transplantation (OLT) survival of 91.7%, middle stage survival of 75%, end stage survival of 33.8%.MARS continues to be the most favorable extracorporeal treatment for liver support therapy in China for a wide range of conditions, including the majority of hepatitis B related liver failure conditions. The appropriate application of MARS for the right indications and stage of hepatic failure, as well as the fulfillment of prescribed treatments, will lead to the optimal therapeutic result." @default.
• W113160711 created "2016-06-24" @default.
• W113160711 creator A5008875927 @default.
• W113160711 creator A5014317773 @default.
• W113160711 creator A5026446016 @default.
• W113160711 creator A5028343495 @default.
• W113160711 creator A5028828133 @default.
• W113160711 creator A5029705326 @default.
• W113160711 creator A5032978434 @default.
• W113160711 creator A5052321704 @default.
• W113160711 creator A5066970325 @default.
• W113160711 creator A5073751749 @default.
• W113160711 creator A5078565848 @default.
• W113160711 creator A5079858305 @default.
• W113160711 creator A5084754315 @default.
• W113160711 date "2008-11-01" @default.
• W113160711 modified "2023-10-14" @default.
• W113160711 title "Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China" @default.
• W113160711 cites W1965553497 @default.
• W113160711 cites W2003488285 @default.
• W113160711 cites W2043398595 @default.
• W113160711 cites W2056075133 @default.
• W113160711 cites W2088488647 @default.
• W113160711 cites W2123879397 @default.
• W113160711 cites W2126180282 @default.
• W113160711 cites W2153039606 @default.
• W113160711 cites W2168105789 @default.
• W113160711 cites W2319836506 @default.
• W113160711 cites W4235369238 @default.
• W113160711 doi "https://doi.org/10.1097/00029330-200811010-00017" @default.
• W113160711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19080184" @default.
• W113160711 hasPublicationYear "2008" @default.
• W113160711 type Work @default.
• W113160711 sameAs 113160711 @default.
• W113160711 citedByCount "7" @default.
• W113160711 countsByYear W1131607112013 @default.
• W113160711 countsByYear W1131607112014 @default.
• W113160711 countsByYear W1131607112016 @default.
• W113160711 countsByYear W1131607112017 @default.
• W113160711 crossrefType "journal-article" @default.
• W113160711 hasAuthorship W113160711A5008875927 @default.
• W113160711 hasAuthorship W113160711A5014317773 @default.
• W113160711 hasAuthorship W113160711A5026446016 @default.
• W113160711 hasAuthorship W113160711A5028343495 @default.
• W113160711 hasAuthorship W113160711A5028828133 @default.
• W113160711 hasAuthorship W113160711A5029705326 @default.
• W113160711 hasAuthorship W113160711A5032978434 @default.
• W113160711 hasAuthorship W113160711A5052321704 @default.
• W113160711 hasAuthorship W113160711A5066970325 @default.
• W113160711 hasAuthorship W113160711A5073751749 @default.
• W113160711 hasAuthorship W113160711A5078565848 @default.
• W113160711 hasAuthorship W113160711A5079858305 @default.
• W113160711 hasAuthorship W113160711A5084754315 @default.
• W113160711 hasBestOaLocation W1131607111 @default.
• W113160711 hasConcept C126322002 @default.
• W113160711 hasConcept C146357865 @default.
• W113160711 hasConcept C151730666 @default.
• W113160711 hasConcept C203014093 @default.
• W113160711 hasConcept C2522874641 @default.
• W113160711 hasConcept C2776283816 @default.
• W113160711 hasConcept C2777214474 @default.
• W113160711 hasConcept C2777382497 @default.
• W113160711 hasConcept C2779609443 @default.
• W113160711 hasConcept C2780306776 @default.
• W113160711 hasConcept C2780325230 @default.
• W113160711 hasConcept C2780434524 @default.
• W113160711 hasConcept C2780593183 @default.
• W113160711 hasConcept C2911091166 @default.
• W113160711 hasConcept C2992208098 @default.
• W113160711 hasConcept C71924100 @default.
• W113160711 hasConcept C86803240 @default.
• W113160711 hasConcept C90924648 @default.
• W113160711 hasConceptScore W113160711C126322002 @default.
• W113160711 hasConceptScore W113160711C146357865 @default.
• W113160711 hasConceptScore W113160711C151730666 @default.
• W113160711 hasConceptScore W113160711C203014093 @default.
• W113160711 hasConceptScore W113160711C2522874641 @default.
• W113160711 hasConceptScore W113160711C2776283816 @default.
• W113160711 hasConceptScore W113160711C2777214474 @default.
• W113160711 hasConceptScore W113160711C2777382497 @default.
• W113160711 hasConceptScore W113160711C2779609443 @default.
• W113160711 hasConceptScore W113160711C2780306776 @default.
• W113160711 hasConceptScore W113160711C2780325230 @default.
• W113160711 hasConceptScore W113160711C2780434524 @default.
• W113160711 hasConceptScore W113160711C2780593183 @default.
• W113160711 hasConceptScore W113160711C2911091166 @default.
• W113160711 hasConceptScore W113160711C2992208098 @default.
• W113160711 hasConceptScore W113160711C71924100 @default.
• W113160711 hasConceptScore W113160711C86803240 @default.
• W113160711 hasConceptScore W113160711C90924648 @default.
• W113160711 hasIssue "21" @default.
• W113160711 hasLocation W1131607111 @default.
• W113160711 hasLocation W1131607112 @default.
• W113160711 hasOpenAccess W113160711 @default.
• W113160711 hasPrimaryLocation W1131607111 @default.
• W113160711 hasRelatedWork W1998599474 @default.
• W113160711 hasRelatedWork W2048589040 @default.
• W113160711 hasRelatedWork W2371296194 @default.

• next